| Dr Melinda A Sherman, PHARM D | |
|
1441 Constitution Blvd, Salinas, CA 93906-3100 | |
| (831) 755-4367 | |
| Not Available |
| Full Name | Dr Melinda A Sherman |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 1441 Constitution Blvd, Salinas, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083915177 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | C45417 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melinda A Sherman, PHARM D 26141 Legends Ct, Salinas, CA 93908-1573 Ph: (831) 596-8973 | Dr Melinda A Sherman, PHARM D 1441 Constitution Blvd, Salinas, CA 93906-3100 Ph: (831) 755-4367 |
News Archive
Eggs take a long time to produce in the ovary, and thus are one of a body's precious resources. It has been theorized that the body has mechanisms to help the ovary ensure that ovulated eggs enter the reproductive tract at the right time in order to maximize the chance of successful fertilization.
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that the U.S. Patent and Trademark Office (USPTO) issued a composition of matter patent covering its clinical candidate, MRX-I. MRX-I is a novel antibacterial oxazolidinone that targets infections due to multi-drug resistant Gram-positive pathogens.
Inspire Pharmaceuticals, Inc. announced today patient enrollment is complete in three of its late-stage clinical trials.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that two oral podium presentations on the company's lead candidate, PRX302, will be made at the 2010 Annual Meeting of the American Urological Association (AUA). These presentations will include six month data from the Phase 2b clinical study of PRX302 called TRIUMPH, in patients with moderate to severe benign prostatic hyperplasia (BPH).
› Verified 9 days ago
Tram Nguyen Dao, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 880 Northridge Ctr, Salinas, CA 93906 Phone: 831-449-2481 | |
Dr. Diego Garcia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 N Main St, Salinas, CA 93906 Phone: 831-751-0260 | |
Jingjing Zhang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8063 San Miguel Canyon Rd, Salinas, CA 93907 Phone: 831-663-2135 | |
Dr. Austin Lee Wahle, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1532 N Main St, Salinas, CA 93906 Phone: 831-443-8717 Fax: 831-883-0413 | |
Uma Valliu, RPH-60896 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1441 Constitution Blvd, Natividad Medical Center, Salinas, CA 93906 Phone: 831-755-4111 | |
Erick James Lawton, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 105 Casentini St Apt H, Salinas, CA 93907 Phone: 208-233-4419 |